{"result": {"id": "7d1fc352-c117-4d13-bcda-dce3862e35ff", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>HEALTH CHINA ACTION (2019-2030)<|>EVENT<|>A national health initiative aimed at improving public health in China by 2030\")\n##\n(\"entity\"<|>NATIONAL BASIC HYPERTENSION PREVENTION AND MANAGEMENT GUIDELINE 2020<|>EVENT<|>Guidelines for the prevention and management of hypertension at the primary care level in China\")\n##\n(\"entity\"<|>CHINA LIPID MANAGEMENT GUIDELINE (2023 VERSION)<|>EVENT<|>Comprehensive guidelines for lipid management in China\")\n##\n(\"entity\"<|>CHINA LIPID MANAGEMENT GUIDELINE (BASIC VERSION 2024)<|>EVENT<|>Simplified guidelines for lipid management at the primary care level in China\")\n##\n(\"entity\"<|>CHINA HYPERTENSION PREVENTION AND TREATMENT GUIDELINE 2018 REVISED EDITION<|>EVENT<|>Updated guidelines for hypertension prevention and treatment in China\")\n##\n(\"entity\"<|>LIPID ABNORMALITY BASIC DIAGNOSIS AND TREATMENT GUIDELINE (PRACTICE VERSION 2019)<|>EVENT<|>Practical guidelines for the diagnosis and treatment of lipid abnormalities at the primary care level\")\n##\n(\"entity\"<|>CHINA HYPERTENSION PATIENTS BLOOD PRESSURE AND LIPID COMPREHENSIVE MANAGEMENT EXPERT CONSENSUS<|>EVENT<|>Expert consensus on the comprehensive management of blood pressure and lipids in hypertensive patients in China\")\n##\n(\"relationship\"<|>HEALTH CHINA ACTION (2019-2030)<|>NATIONAL BASIC HYPERTENSION PREVENTION AND MANAGEMENT GUIDELINE 2020<|>Both are part of China's efforts to improve public health and manage chronic diseases<|>5)\n##\n(\"relationship\"<|>CHINA LIPID MANAGEMENT GUIDELINE (2023 VERSION)<|>CHINA LIPID MANAGEMENT GUIDELINE (BASIC VERSION 2024)<|>The basic version is a simplified adaptation of the comprehensive 2023 version for primary care<|>7)\n##\n(\"relationship\"<|>CHINA HYPERTENSION PREVENTION AND TREATMENT GUIDELINE 2018 REVISED EDITION<|>NATIONAL BASIC HYPERTENSION PREVENTION AND MANAGEMENT GUIDELINE 2020<|>Both provide guidelines for hypertension management, with the 2020 version focusing on primary care<|>6)\n##\n(\"relationship\"<|>LIPID ABNORMALITY BASIC DIAGNOSIS AND TREATMENT GUIDELINE (PRACTICE VERSION 2019)<|>CHINA LIPID MANAGEMENT GUIDELINE (BASIC VERSION 2024)<|>Both are simplified guidelines for lipid management at the primary care level<|>5)\n##\n(\"relationship\"<|>CHINA HYPERTENSION PATIENTS BLOOD PRESSURE AND LIPID COMPREHENSIVE MANAGEMENT EXPERT CONSENSUS<|>CHINA HYPERTENSION PREVENTION AND TREATMENT GUIDELINE 2018 REVISED EDITION<|>Both address hypertension management, with the consensus focusing on combined blood pressure and lipid management<|>6)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165636, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 711, "prompt_tokens": 2404, "total_tokens": 3115, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 612}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 自我健康管理\n制定个性化的诊疗计划和管理方案\n与临床专科和社区卫生服务中心合作，优化双向转诊路径\n按照疾病轻重缓急和治疗难易程度进行分级\n达到基层首诊、双向转诊、急慢分治和上下联动\n\n图 1  基层医疗机构医防融合规范化管理理念\n\n\n学科诊断和处理方法。治疗决策：基于现有的最佳 医学证据，临床路径制定和实施的全过程均建议以  临床路径管理的相关数据为参考，对多病共存的慢  性病患者进行持续性、综合性、个体化的全程追踪  管理。管理过程：医患之间需要充分沟通，让患者  知晓治疗方案，并充分尊重患者意愿，完善实施方  案。对实施过程存在的障碍建议及时解决，必要时  可寻求多方帮助，以确保治疗和健康管理的延续和  复诊评估的定期开展。分级诊疗制度：旨在按疾病 轻重缓急和治疗难易程度进行分级，不同级别的医  疗机构承担相应严重程度的疾病诊疗，实现基层首  诊、双向转诊、急慢分治和上下联动，有效配置医  疗卫生资源［20］。通过双向转诊绿色通道、疾病精  细化管理、慢病一体化管理、建立区域信息平台等  方式，整合各级医疗卫生健康数据，实现多方联动、 分级诊疗，这也是基层慢性病多病共存健康管理的  发展趋势［21-22］。\n\n\n2 本共识制定形成的方法与过程\n2.1 本共识制定依据及意义\n　　　本共识参考国内外高血压和血脂异常的最新医 学进展，参考的指南、文件、共识主要包括《健康 中国行动（2019-2030 年）》［23］《国家基层高血压 防治管理指南 2020 版》［24］《中国血脂管理指南（2023 版）》［25］《中国血脂管理指南（基层版 2024 年）》［26］ 《中国高血压防治指南 2018 年修订版》［27］《血脂异 常基层诊疗指南（实践版 ·2019）》［28］《中国高血 压患者血压血脂综合管理的专家共识》［29］ 等。借鉴 医疗信息互联互通、人工智能、互联网医疗服务等新 技术、新方法、新思维， 学习国内医联体建设的先进 经验。在总结国内外相关科学文献证据、国内外学术 组织相关标准和指南的基础上， 广泛征求国内相关专 家的意见与建议，结合试点实践经验总结综合制定。\n　　通过开展高血压和血脂异常共存的规范化管 理，以医防融合为导向，可以：①切实有效落实以\n\n\n\n2025 年第 1 期    第 22 卷       3   \n\n\n 标准与讨论\n\n\n\n　健康为中心的慢病健康管理理念。②探索联合多学\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_4fe5f93a2e314e2fcf4fa4ee68e82bcb1cc1401ca17e40238e63f69f3a476092_v2"}